JH-VIII-157-02
JH-VIII-157-02 is a structural analogue of alectinib, acts as an ALK inhibitor, and shows an IC50 of 2 nM for echinoderm microtubule-associated protein-like 4-ALK (EML4-ALK) G1202R in cells.
Product Specifications
CAS Number
1639422-97-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Anaplastic lymphoma kinase (ALK)
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/JH-VIII-157-02.html
Concentration
10mM
Purity
98.98
Solubility
DMSO : ≥ 25 mg/mL
Smiles
O=C(N(C)C)CN1N=CC(C2=C(CC)C=C3C(C(C)(C)C(NC4=C5C=CC(C#N)=C4)=C5C3=O)=C2)=C1
Molecular Formula
C28H27N5O2
Molecular Weight
465.55
Precautions
H302, H315, H319, H335
References & Citations
[1]Hatcher JM, et al. Discovery of Inhibitors That Overcome the G1202R Anaplastic Lymphoma Kinase Resistance Mutation. J Med Chem. 2015 Dec 10;58 (23) :9296-9308.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY422850 100 µg
Shugoshin (SGO1) (NM_001012412) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC882099-500 1x 500 µL
Catenin, beta (p120) (CTNNB1/2099), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472743-500 1x 500 µL
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2743), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
AP15198PU-N 400 µL
PI 3 Kinase catalytic subunit gamma (PIK3CG) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details